Jagdeesh Natesan¹, S Krishnan^2,3* and Susmita Chowdhuri^2,3

¹Boston University, MA, Detroit, MI, USA
²Wayne State University, Detroit, MI, USA
³John D. Dingell VA Medical Center, Detroit, MI, USA

*Corresponding Author: S Krishnan, Wayne State University, Detroit, MI, USA.

Received: March 05, 2024; Published: April 08, 2024

Abstract

The COVID-19 pandemic has made a major impact on global health and economy over the last year. With new variants emerging, several countries are currently going through a 3rd surge with a high risk for severe disease and mortality in the unvaccinated individuals. Despite significant data published over the last year, several questions remain unanswered and COVID-19 remains an enigma. Most importantly, risk factors that increase a person’s risk for severe disease and mortality have not been clearly defined. Some of the standard comorbidities such as old age, obesity, diabetes, hypertension, respiratory or cardiovascular disease, and immunocompromised status have been reported as the major risk factors. Several pulmonology experts have hypothesized that OSA may be an independent risk factor for severe COVID-19, although the answer remains unclear. This article is a brief overview of currently available literature that links COVID-19 and OSA, focusing on OSA as an independent risk factor for severe COVID-19. It also emphasizes that early diagnosis and treatment of OSA with PAP is critical, as it decreases the risk for long-term (cardiovascular and cerebrovascular) complications thereby improving overall morbidity and mortality in these patients.

 Keywords: Sleep Apnea; COVID 19; Long COVID; Public Health

References

1. Richardson Safiya., et al. “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area”. JAMA20 (2020): 2052-2059.
2. Grasselli G., et al. “Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy”. JAMA16 (2020): 1574-1581.
3. Gottlieb DJ and Punjabi NM. “Diagnosis and Management of Obstructive Sleep Apnea: A Review”. JAMA 14 (2020): 1389-1400.
4. Rana D., et al. “Obstructive Sleep Apnea and Cardiovascular Morbidities: A Review Article”. Cureus 9 (2020): e10424.
5. Tufik S. “Obstructive Sleep Apnea as a comorbidity to Covid-19”. Sleep Science3 (2020): 181-182.
6. Tufik S., et al. “Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?” Journal of Clinical Sleep Medicine8 (2020): 1425-1426.
7. Saxena K., et al. “COVID 19 and OSA: exploring multiple cross-ways”. Sleep Medicine 79 (2021): 223.
8. Jose RJ and Manuel A. “COVID-19 cytokine storm: the interplay between inflammation and coagulation”. Lancet Respiratory Medicine6 (2020): e46-e47.
9. Strausz S., et al. “Sleep apnoea is a risk factor for severe COVID-19”. BMJ Open Respiratory Research1 (2021): e000845.
10. Cariou B., et al. “CORONADO investigators. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study”. Diabetologia 8 (2020): 1500-1515.
11. Maas MB., et al. “Obstructive Sleep Apnea and Risk of COVID-19 Infection, Hospitalization and Respiratory Failure”. Sleep Breath2 (2021): 1155-1157.
12. Peker Y., et al. “OSACOVID-19 Study Collaborators. Effect of High-Risk Obstructive Sleep Apnea on Clinical Outcomes in Adults with Coronavirus Disease 2019: A Multicenter, Prospective, Observational Cohort Study”. Annals of the American Thoracic Society (2021).
13. Hariyanto TI and Kurniawan A. “Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis”. Sleep Medicine 82 (2021): 47-53.
14. Cade BE., et al. “Sleep Apnea and Poor COVID-19 Outcomes: Beware of Causal Intermediates and Colliders”. American Journal of Respiratory and Critical Care Medicine 10 (2021): 1326-1327.
15. Najafi A., et al. “The effect of apnea management on novel coronavirus infection: A study on patients with obstructive sleep apnea”. Sleep Health1 (2021): 14-14.
16. Attias D., et al. “Impact of COVID-19 lockdown on adherence to continuous positive airway pressure by obstructive sleep apnoea patients”. European Respiratory Journal1 (2020): 2001607.
17. Salles C., et al. “COVID-19 and obstructive sleep apnea”. Journal of Clinical Sleep Medicine9 (2020): 1647.
18. Mello MT., et al. “Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment”. Sleep Science3 (2020): 199-209.
19. , et al. “On behalf of the RECOVER Consortium, Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative”. Sleep 46.9 (2023): zsad126.
20. Ekiz T., et al. “Obstructive sleep apnea, renin- angiotensin system, and COVID-19: possible interactions”. Journal of Clinical Sleep Medicine8 (2020): 1403-1404.
21. Gottlieb M., et al. “Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois”. Academic Emergency Medicine 10 (2020): 963-973.
22. Goyal A., et al. “Obstructive sleep apnea is highly prevalent in COVID19 related moderate to severe ARDS survivors: findings of level I polysomnography in a tertiary care hospital”. Sleep Medicine 19 (2021): S1389-9457 (21)00350-6.

Citation

Citation: S Krishnan., et al. “Obstructive Sleep Apnea, COVID-19 and Risk for Long COVID: A Conundrum”.Acta Scientific Medical Sciences 8.5 (2024): 29-34.

Copyright

Copyright: © 2024 S Krishnan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.